What is NDC 71656-072?

71656-072 is the product NDC for Lithium, Lithium citrate 8 meq/5mL solution, listed with the FDA by Saptalis Pharmaceuticals, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

Saptalis Pharmaceuticals, LLC, NDC labeler code 71656. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lithium?

7 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lithium NDC 71656-072 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71656-072Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71656-0072Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71656-072-16	7165600721671656007216	473 mL in 1 BOTTLE (71656-072-16)Marketed from Apr 5, 2024
71656-072-50	7165600725071656007250	5 TRAY in 1 CASE (71656-072-50) / 10 CUP in 1 TRAY / 5 mL in 1 CUP (71656-072-05)Marketed from Mar 28, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lithium
Generic name (nonproprietary): lithium
Active ingredients: Lithium citrate — 8 meq/5mL
Dosage form: Solution
Route: Oral
Labeler: Saptalis Pharmaceuticals, LLCNDC labeler code 71656
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217183
Marketing start: Mar 28, 2024
Listing expires: Dec 31, 2026
Identifiers: Product ID 71656-072_3ccc30e9-1f5d-5715-e063-6394a90a6bc1SPL ID 3ccc30e9-1f5d-5715-e063-6394a90a6bc1SPL set ID e95036c7-542a-437a-969b-f95f6f949f84RxCUI 756059UNII 5Z6E9K79YV
Pharmacologic class: Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471656007216 followed by a unit qualifier and the quantity

Package 71656-0072-16. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 20, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Lithium oral solution is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: Treatment of acute manic and mixed episodes in patients 7 years and older [see Clinical Studies ( 14 )]. Maintenance treatment in patients 7 years and older [see Clinical Studies ( 14 )]. Lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: Treatment of acute manic and mixed episodes in patients 7 years and older ( 1 ). Maintenance treatment in patients 7 years and older ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71656-072

What is NDC 71656-072?: 71656-072 is the product NDC for Lithium, Lithium citrate 8 meq/5mL solution, listed with the FDA by Saptalis Pharmaceuticals, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lithium.
What is the active ingredient?: Lithium citrate.
Who is the labeler?: Saptalis Pharmaceuticals, LLC, NDC labeler code 71656. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lithium?: 7 other product NDCs are listed under this name. See all Lithium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lithium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lithium	Lithium citrate 8 meq/5mL	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-1027	00121-1027-16
Lithium	Lithium citrate 8 meq/5mL	SolutionOral	PAI Holdings, LLC dba PAI Pharma	0121-4027	00121-4027-94
Lithiumlithium citrate	Lithium citrate 8 meq/5mL	SolutionOral	Precision Dose, Inc.	68094-077	68094-0077-62
Lithium	Lithium citrate 8 meq/5mL	SolutionOral	REMEDYREPACK INC.	70518-4227	70518-4227-0070518-4227-02
Lithium	Lithium citrate 8 meq/5mL	SolutionOral	Advagen Pharma Ltd	72888-172	72888-0172-46
Lithium	Lithium citrate 8 meq/5mL	SolutionOral	Atlantic Biologicals Corp.	17856-1172	17856-1172-01
Lithiumlithium bromatum	Lithium bromide 3 [hp_X]/mL	LiquidOral	Marco Pharma International LLC.	60986-1019	60986-1019-0360986-1019-04